MedPath

Use of Sentinel Cells for the Development of Molecular Tests to Control the Quality of Cryopreservation

Withdrawn
Conditions
Aneurysm of the Abdominal Aorta
Registration Number
NCT01904825
Lead Sponsor
Centre Hospitalier Universitaire Dijon
Brief Summary

The aim is to set up tools that will serve as quality tracers for cryopreservation procedures.

To meet this objective, we have chosen to develop reference samples (sentinel cells) that, in the medium term, can be used as controls to guarantee the quality of preservation for biological samples.

The biological tools and an optimised follow-up strategy will make it possible to validate preservation procedures at the CRB in order to guarantee the perfect stability of samples and the validity of clinical studies.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Age > or = 18 years
  • All patients presenting an abdominal aorta diameter of at least 5 cm at the time of discovery and who have surgery
Exclusion Criteria
  • Patients who do not have aneurysm of the abdominal aorta
  • Refusal to sign the consent form for participation
  • Patients who do not wish to have their operation in Dijon or Strasbourg CHU

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality sentinel cellsparticipants will be followed for the duration of hospital stay, an expected average of 6 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath